Catalyst
Slingshot members are tracking this event:
BioCryst Receives Additional NIAID Funding to Advance Development of BCX4430 to Treat Hemorrhagic Fever Virus Diseases
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
BCRX |
|
|
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 05, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Niaid Funding, Bcx4430, Hemorrhagic Fever Virus Diseases, Niaid, Ebola, Zeka, Marburg